fda bpc-157 warning unapproved drug new peptide safety risks The FDA has issued clear signals BPC-157 FDA Approval Status 2026: – fda warning bpc-157 unapproved drug

Many of the signatories have left messages crediting peptides with improving their health

None of those are compatible with the regenerative signaling that GHK-Cu is sending

Neither is "better" in a research sense, because the two are studied for different mechanistic questions

The lyophilized powder is a white, hygroscopic solid that should be protected from light and moisture

"In addition, some of our members have observed that some FDA reviewers seem to be applying the thresholds in the EMA guideline during their reviews, although FDA has not announced its intention to do so, and other FDA reviewers may be taking a different approach." AAM asked FDA to publish a more detailed guidance clarifying expectations for establishing thresholds for impurities to avoid changing expectations and inconsistent reviews

Balenovic D et al